Gestational Trophoblastic Neoplasia Meeting (GTN)

Gestational Trophoblastic Neoplasia Meeting (GTN)

Accreditation
Target Audience:
  • Obstetricians and Gynecologists already in practice or completing residency training
  • Gynecologic Oncologists and Gynecologic Oncology Fellows
  • Medical Oncologists and Radiation Oncologists who treat gynecologic malignancies
Course Format: A mix of keynote and case based presentations
UBC Robson Square
800 Robson St.
Vancouver BC
Full-Sized Map

Overview

Offering a rare opportunity for Obstetricians/Gynecologists and Oncologists to be immersed in a full day of education and discussion about the treatment of gestational trophoblastic neoplasms (GTNs) with a recognized international expert in the field, Dr. Philip Savage, and members of the BC Gynecologic Oncology Tumour group.  Common and complex scenarios will be discussed, including illustrative case-studies . Participant engagement will be encouraged.

Agenda

Thursday May 4


0800 Breakfast, Registration  & Exhibits Open        
0845 Opening Remarks & Welcome - Dr. Anna Tinker
         PART ONE: GENERAL OVERVIEW        
0900 GTN Common Presentations & Diagnosis - Dr. Lily Proctor
0920 Pathology of GTN - Dr. Lien Hoang
0940 Role of Surgery - Dr. Sarah Finlayson
0955 Determining Risk & Need For Treatment - Dr. Annick Pina
1015 Break        
         PART TWO:  TREATMENT OF LOW RISK DISEASE        
1030 Watchful Waiting – When Can It Be Done? - Dr. Anna Tinker
1040 Treatment of Low-Risk Disease - Dr. Phillippe Sauthier
1100 The BCCA Approach to Low Risk GTN - Dr. Paul Hoskins
1120 Hereditary GTN - Dr. Jenny Ko
1140 Appropriate Follow Up After Treatment of GTN & Proceeding with Pregnancy - Dr. Trevor Cohen
1200 Lunch         
         PART THREE:  TREATMENT OF HIGH RISK DISEASE        
1300 Multi-Agent Treatment for High Risk GTN - Dr. Philip Savage
1320 Management of Acute/Urgent Presentations (Case-Based)
           - CNS Mets - Dr. Philip Savage
           - Hemoptysis - Dr. Jennifer Rauw
           - Pelvic Bleeding - Dr. Philip Savage
1405 The HGCs have Plateaued - What Next? - Dr. Philip Savage
1435 Treatment of Residual Uterine AVM - Dr. Marette Lee
1450 Break        
1505 3x CASE PRESENTATIONS
         - Intraplacental Choriocarcinoma – What to Do? - Dr. Jennifer Rauw
         - Slowly Rising HCG Post Low-Risk Treatment - Dr. Anna Tinker
         - Non-Gonadal/Non-Gestational HCG Secreting Tumour - Dr. Nevin Murray
1550 Complete Evaluation         
1610 Conference Ends        

Key Speakers

Philip Savage, BSc, MB ChB, PhD, FRCP. Consultant Medical Oncologist BSUH UK (Formerly Consultant Medical Oncologist, UK Trophoblast Disease Service, Charing Cross Hospital, London)

Cost

Early bird registration: Mon. Jan 23, 2017 | Add to calendar +

Fees include course materials, breakfasts, refreshments & lunch  

By Apr 24/17:
Conference Fees:  $125
Residents & Student Fees: $50
 
After Apr 24/17:
Conference Fees:  $135
Residents & Student Fees: $50
Cancellations and Refunds

You May Also Like

Target Audience:

Obstetricians, family physicians, perinatologists, internists and subspecialists, obstetric anesthesiologists, midwives, maternity nurses, residents & students

Date: Apr 22, 2017
Location:
Sheraton Wall Centre Hotel
1088 Burrard St
Vancouver  British Columbia  V6Z 2R9
Canada
Top
More »